东富龙：公司严格按照重大合同的标准履行信息披露义务

Core Viewpoint - The company emphasizes its commitment to information disclosure and reports significant growth in international business revenue, alongside a focus on technological innovation and strategic growth opportunities [1] Group 1: Financial Performance - In the first half of 2025, the company achieved international business revenue of 805 million yuan, accounting for 33.14% of total revenue, representing a year-on-year growth of 63.25% [1] Group 2: Strategic Focus - The company is committed to technological innovation and plans to increase investment in research and development, focusing on key technologies and processes in the pharmaceutical and equipment industries [1] - The company aims to continuously develop new products and improve existing ones to create a portfolio of core competitive products [1] Group 3: Growth Opportunities - The company will actively seek new external growth opportunities, considering business layout, synergy effects, innovation, and uniqueness, to achieve a coordinated development of both internal and external growth [1]